Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.6500
-0.0034 (-0.52%)
Oct 8, 2026, 1:48 PM EDT - Market open
Envoy Medical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Envoy Medical stock has a consensus rating of "Strong Buy" and an average price target of $2.17. The average 1-year stock price forecast is 233.85% higher than the current stock price, while the lowest is $2.00 (+207.69%) and the highest is $2.50 (+284.62%).
Price Target: $2.17 (+233.85%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Envoy Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Mar '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Initiates $2.5 | Buy | Initiates | $2.5 | +284.62% | Oct 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $2.5 → $2 | Buy | Reiterates | $2.5 → $2 | +207.69% | Aug 21, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $2 | Buy | Initiates | $2 | +207.69% | Jul 27, 2026 |
Financial Forecast
Revenue This Year
233.33K
from 241.00K
Decreased by -3.18%
Revenue Next Year
273.33K
from 233.33K
Increased by 17.14%
EPS This Year
-0.29
from -1.23
EPS Next Year
-0.24
from -0.29
EPS and Forward PE are based on non-GAAP adjusted numbers.